Grant: Idea to Innovation
Université de Sherbrooke
$13,125.00
Market assessment applications of EAPAMM
EF 2010-11
Résumé
Elastically Averaged Pneumatic Air Muscle Manipulator (EAPAMM )for MRI
One of the most recurrent cancer is the prostate cancer. In the US, prostate cancer represents 25% of all new cancer cases and killed 25 000 men in 2009. Early diagnosis of prostate cancer is giving nearly a hundred percent chance of survival to patients compared to 32% survival rate when malignant tumor has spread. Magnetic Resonance Image (MRI) guided interventions can improve early detection. MRI is a challenging environment because of the strong magnetic field. The proposed research develops a cost effective mechatronic device: the Elastically Averaged Pneumatic Air Muscles Manipulator (EAPAMM) for MRI-guided biopsy and treatment of prostate cancer. As an example, EAPAMM positions a needle in an optimal trajectory to precisely reach early stage tumors identified by MRI, thereby improving intervention accuracy and reducing procedure time compared to current manual ultrasound techniques. The EAPAMM consists in three subsystems: an orientation module, a stack of 12 all-polymer pneumatic valves, an insertion module, and polymer position sensors and binary control. A first laboratory-grade prototype demonstrated an averaged repeatability as low as 0.5 mm and an averaged accuracy of 2.1mm. The objectives of the proposed work are to: (1) design and fabricate a fully functional and optimized EAPAMM prototype and (2) demonstrate the prototype suitability and accuracy by performing MRI-guided needle insertions in phantoms. While the commercial potential of EAPAMM is obvious, the final product is to be integrated to the medical field. In turn, the success of this commercialization will be led by acceptance from health professionals and health organizations. Since many steps need to be taken to reach this level, a good understanding of the market and its needs will be determinant in order to adapt and guide the development of EAPAMM toward a successful commercialization.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
401613-2010
Name nom
Plante, JeanSébastien
Department département
Génie mécanique
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2010
Award amount
13125
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
2600
Research subject group en
Robotics
Research subject group fr
Robotique
Research subject en
Robotics
Research subject fr
Robotique
Partie
1
Nb partie
1
Application title
Market assessment applications of EAPAMM
Keyword
NSERC
Application summary
Elastically Averaged Pneumatic Air Muscle Manipulator (EAPAMM )for MRI
One of the most recurrent cancer is the prostate cancer. In the US, prostate cancer represents 25% of all new cancer cases and killed 25 000 men in 2009. Early diagnosis of prostate cancer is giving nearly a hundred percent chance of survival to patients compared to 32% survival rate when malignant tumor has spread. Magnetic Resonance Image (MRI) guided interventions can improve early detection. MRI is a challenging environment because of the strong magnetic field. The proposed research develops a cost effective mechatronic device: the Elastically Averaged Pneumatic Air Muscles Manipulator (EAPAMM) for MRI-guided biopsy and treatment of prostate cancer. As an example, EAPAMM positions a needle in an optimal trajectory to precisely reach early stage tumors identified by MRI, thereby improving intervention accuracy and reducing procedure time compared to current manual ultrasound techniques. The EAPAMM consists in three subsystems: an orientation module, a stack of 12 all-polymer pneumatic valves, an insertion module, and polymer position sensors and binary control. A first laboratory-grade prototype demonstrated an averaged repeatability as low as 0.5 mm and an averaged accuracy of 2.1mm. The objectives of the proposed work are to: (1) design and fabricate a fully functional and optimized EAPAMM prototype and (2) demonstrate the prototype suitability and accuracy by performing MRI-guided needle insertions in phantoms. While the commercial potential of EAPAMM is obvious, the final product is to be integrated to the medical field. In turn, the success of this commercialization will be led by acceptance from health professionals and health organizations. Since many steps need to be taken to reach this level, a good understanding of the market and its needs will be determinant in order to adapt and guide the development of EAPAMM toward a successful commercialization.